Biocompatibility testing in Medical Devices Conference 2020 will give you the unique opportunity to discuss the most pressing issues and meet the representatives of the biggest companies and leaders from Biocompatibility and Medical Device Industries Biocompatibility testing in Medical Devices Conference 2020 is a great platform for learning, exchanging opinions, and expanding one’s network enabled by live presentations […]
Senzagen will be presenting a poster at the ASCCT meeting on Oct 20 from 4:45-6 pm EDT. Come join us to learn about how the GARDskin Dose-Response assay can be used for quantitative potency assessment!
In Vitro Skin Sensitization Testing with Human Relevance and High Accuracy In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for assessment of skin sensitization hazard in medical device extracts, prepared according to ISO 10993-12. What You Will Learn Attendees will gain insights into: How GARD™skin Medical […]
Wednesday, October 28, 2020 11:05 a.m. PT Joshua Schmidt, SenzaGen, Inc. "Leveraging in vitro to forecast in vivo success"
New Approach Methodology Use for Regulatory Application (NURA) in collaboration with the Association for the Advancement of Alternatives Assessment (A4) is hosting two half day trainings to explore practical solutions for the safety assessment of cosmetics and consumer products. Lectures, discussions, and demonstrations will help attendees evaluate the advantages of new nonanimal approaches and apply them to […]
Monday November 16, 2020 5:00 PM–6:30 PM EST Virtual Poster Session: Dose-Response Analysis in GARD for Assessment of Skin Sensitizer Potency Applicability of GARDskin for Accurate Assessment of Challenging Substances in the Context of Skin Sensitization Testing
This day is offering a theoretical base with different lectures on research forefront and financing opportunities. The workshop originally included a practical session on site, but due to the covid-19 situation this session must be postponed. Researchers from different universities, research institutes and companies are participating in the program, that will last from 1 PM […]
Dec. 1st at 1:10pm EDT As part of the "Sensitization: Skin & Beyond" science panel, Dr. Andy Forreryd at SenzaGen will be presenting a talk titled: "The GARD Platform for Skin and Respiratory Sensitization Testing: Practical Applications and Case Studies". Don't miss Andy's talk and register today!
In vitro, high accuracy, broad applicability Join this free webinar to learn how the GARD™ assays, based on genomics and machine learning, provide a highly accurate method for skin sensitization hazard and potency assessment of chemicals, including “difficult-to-test” substances. Key topics: An introduction to the prediction model, genomics and machine learning technology The broad applicability […]
User cases on hazard and potency assessment Join us for this free webinar to get the latest news about the in vitro GARD™ assays and how they are used across various industries to fill data gaps in sensitizing hazard and potency assessment of chemicals and medical devices. Key topics We will provide several user cases […]
